301 related articles for article (PubMed ID: 21235313)
1. Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas.
Sherman JH; Moldovan K; Yeoh HK; Starke RM; Pouratian N; Shaffrey ME; Schiff D
J Neurosurg; 2011 Jun; 114(6):1617-21. PubMed ID: 21235313
[TBL] [Abstract][Full Text] [Related]
2. Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide.
Koekkoek JA; Dirven L; Heimans JJ; Postma TJ; Vos MJ; Reijneveld JC; Taphoorn MJ
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):366-73. PubMed ID: 25055819
[TBL] [Abstract][Full Text] [Related]
3. Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide.
Koekkoek JA; Dirven L; Heimans JJ; Postma TJ; Vos MJ; Reijneveld JC; Taphoorn MJ
J Neurooncol; 2016 Jan; 126(2):347-54. PubMed ID: 26547911
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide in low-grade gliomas: living longer and better.
Rees J
J Neurol Neurosurg Psychiatry; 2015 Apr; 86(4):359-60. PubMed ID: 25189160
[No Abstract] [Full Text] [Related]
5. Seizure control: a secondary benefit of chemotherapeutic temozolomide in brain cancer patients.
Hu A; Xu Z; Kim RY; Nguyen A; Lee JW; Kesari S
Epilepsy Res; 2011 Aug; 95(3):270-2. PubMed ID: 21549564
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
Brada M; Viviers L; Abson C; Hines F; Britton J; Ashley S; Sardell S; Traish D; Gonsalves A; Wilkins P; Westbury C
Ann Oncol; 2003 Dec; 14(12):1715-21. PubMed ID: 14630674
[TBL] [Abstract][Full Text] [Related]
7. Is There a Role for Temozolomide in Glioma Related Seizures? A Systematic Review.
Yue J; Yin C; Chen L; Xu R; Zhao D
Neurol India; 2022; 70(3):864-871. PubMed ID: 35864610
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide treatment of refractory epilepsy in a patient with an oligodendroglioma.
Ngo L; Nei M; Glass J
Epilepsia; 2006 Jul; 47(7):1237-8. PubMed ID: 16886989
[TBL] [Abstract][Full Text] [Related]
9. Seizure characteristics and control following resection in 332 patients with low-grade gliomas.
Chang EF; Potts MB; Keles GE; Lamborn KR; Chang SM; Barbaro NM; Berger MS
J Neurosurg; 2008 Feb; 108(2):227-35. PubMed ID: 18240916
[TBL] [Abstract][Full Text] [Related]
10. Dynamic history of low-grade gliomas before and after temozolomide treatment.
Ricard D; Kaloshi G; Amiel-Benouaich A; Lejeune J; Marie Y; Mandonnet E; Kujas M; Mokhtari K; Taillibert S; Laigle-Donadey F; Carpentier AF; Omuro A; Capelle L; Duffau H; Cornu P; Guillevin R; Sanson M; Hoang-Xuan K; Delattre JY
Ann Neurol; 2007 May; 61(5):484-90. PubMed ID: 17469128
[TBL] [Abstract][Full Text] [Related]
11. An extent of resection threshold for seizure freedom in patients with low-grade gliomas.
Xu DS; Awad AW; Mehalechko C; Wilson JR; Ashby LS; Coons SW; Sanai N
J Neurosurg; 2018 Apr; 128(4):1084-1090. PubMed ID: 28548599
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of initial temozolomide for high-risk low grade gliomas in a phase II AINO (Italian Association for Neuro-Oncology) study: a post-hoc analysis within molecular subgroups of WHO 2016.
Rudà R; Pellerino A; Pace A; Carapella CM; Dealis C; Caroli M; Faedi M; Bello L; Migliore E; Marchese G; Bertero L; Cassoni P; Soffietti R
J Neurooncol; 2019 Oct; 145(1):115-123. PubMed ID: 31556015
[TBL] [Abstract][Full Text] [Related]
13. Delirium likely caused by interaction between phenytoin and temozolomide.
Levy M
Psychosomatics; 2007; 48(4):359-60. PubMed ID: 17600176
[No Abstract] [Full Text] [Related]
14. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
15. Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response.
Pace A; Vidiri A; Galiè E; Carosi M; Telera S; Cianciulli AM; Canalini P; Giannarelli D; Jandolo B; Carapella CM
Ann Oncol; 2003 Dec; 14(12):1722-6. PubMed ID: 14630675
[TBL] [Abstract][Full Text] [Related]
16. Short-term outcomes and predictors of post-surgical seizures in patients with supratentorial low-grade gliomas.
Jiang H; Liu B; Deng G; Yuan F; Tan Y; Yang K; Gao L; Wang J; Chen Q
J Clin Neurosci; 2020 Feb; 72():163-168. PubMed ID: 31937499
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid, compared to other antiepileptic drugs, is associated with improved overall and progression-free survival in glioblastoma but worse outcome in grade II/III gliomas treated with temozolomide.
Redjal N; Reinshagen C; Le A; Walcott BP; McDonnell E; Dietrich J; Nahed BV
J Neurooncol; 2016 May; 127(3):505-14. PubMed ID: 26830093
[TBL] [Abstract][Full Text] [Related]
18. Low-grade gliomas associated with intractable epilepsy: seizure outcome utilizing electrocorticography during tumor resection.
Berger MS; Ghatan S; Haglund MM; Dobbins J; Ojemann GA
J Neurosurg; 1993 Jul; 79(1):62-9. PubMed ID: 8315470
[TBL] [Abstract][Full Text] [Related]
19. Prolonged administration of temozolomide in adult patients with anaplastic glioma.
Freyschlag CF; Smolczyk DR; Janzen E; Schmieder K; Thomé C; Lohr F; Wenz F; Weiss C; Tuettenberg J; Seiz M
Anticancer Res; 2011 Nov; 31(11):3873-7. PubMed ID: 22110212
[TBL] [Abstract][Full Text] [Related]
20. Temozolomide is active in childhood, progressive, unresectable, low-grade gliomas.
Kuo DJ; Weiner HL; Wisoff J; Miller DC; Knopp EA; Finlay JL
J Pediatr Hematol Oncol; 2003 May; 25(5):372-8. PubMed ID: 12759623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
